another new drug in the migraine pipeline is lasmiditan. it works the same way as triptans. but unlike the triptans, it doesn't constrict
.
.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
.
the comments below have not been moderated.
.
.
.
.
even though the uk is leaving the eu through brexit, the government may still be under the eu�s environmental jurisdiction, according to the guardian.
.
.